Carsten Hjorthøj
0000-0002-6943-4785
10 papers found
Refreshing results…
Interview and Questionnaire Assessment of Cognitive Impairment in Subjects at Ultra-High Risk for Psychosis: Associations with Cognitive Test Performance, Psychosocial Functioning, and Positive Symptoms
Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder
Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
Morbidity and Mortality in the Children and Young Adult Offspring of Parents With Schizophrenia or Affective Disorders—A Nationwide Register-Based Cohort Study in 2 Million Individuals
Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis
Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care – a long-term, population-based study
Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis
Missing publications? Search for publications with a matching author name.